Zobrazeno 1 - 10
of 344
pro vyhledávání: '"Spagnoli LG"'
Autor:
Ravaioli, A, Monti, F, Regan, M, Maffini, F, Mastropasqua, M, Spataro, V, Castiglione Gertsch, M, Panzini, I, Gianni, L, Goldhirsch, A, Coates, A, Price, K, Gusterson, B, Viale, G, Spagnoli, Lg
Publikováno v:
Ravaioli, A.; Monti, F.; Regan, M. M.; Maffini, F.; Mastropasqua, M. G.; Spataro, V.; Castiglione-Gertsch, Monica; Panzini, I.; Gianni, L.; Goldhirsch, A.; Coates, A.; Price, K. N.; Gusterson, B. A.; Viale, G. (2008). p27 and Skp2 immunoreactivity and its clinical significance with endocrine and chemo-endocrine treatments in node-negative early breast cancer. Annals of oncology, 19(4), pp. 660-668. Oxford University Press 10.1093/annonc/mdm547
Background: Low p27 and high Skp2 immunoreactivity are associated with a poor prognosis and other poor prognostic features including resistant phenotypes and antiestrogen drug resistance. We investigated these proteins in two International Breast Can
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ccb73faf5dcafcd00d8b446b62f371d5
http://doc.rero.ch/record/303901/files/mdm547.pdf
http://doc.rero.ch/record/303901/files/mdm547.pdf
Autor:
Macciomei Mc, Passerini-Glazel G, Cavazzana Ao, Lania L, Tommaso Prayer-Galetti, Tirabosco R, Stella M, Cannada-Bartoli P, Spagnoli Lg, Francesco Pagano
Publikováno v:
European Urology. 30:340-344
Objective : Bellini duct carcinoma (BDC) is a rare and highly aggressive renal tumor whose histogenesis is still a matter of debate although a putative origin from collecting ducts has been proposed. Methods : A primary tumor cell culture was obtaine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::700da24b7ba6ee1bfaaec6e51b5c937b
https://doi.org/10.1159/000474193
https://doi.org/10.1159/000474193
Autor:
Capocaccia, R, Berrino, F, De Angelis, R, Ferrantini, M, Gatta, G, Lombardo, L, Micheli, A, Nicoletti, G, Spagnoli, Lg, Vercelli, Marina, Sant, M.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3710::50e0b3b38a550d8755c76c724de22c1c
http://hdl.handle.net/11567/399317
http://hdl.handle.net/11567/399317
Autor:
Sangiorgi, G, Mauriello, A, Kolodgie, F, Trimarchi, S, Biondi Zoccai, G, Virmani, R, Spagnoli, Lg, Type=advanced, R, prevSearch=%2Bauthorsfield%3A%28Sangiorgi%2C+Giuseppe%29
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3667::64e99dbbf384945a790b6d44debdcc34
http://hdl.handle.net/2108/66568
http://hdl.handle.net/2108/66568
Autor:
Pagani, O, Gelber, S, Simoncini, E, Castiglione Gertsch, M, Price, K, Gelber, R, Holmberg, S, Crivellari, D, Collins, J, Lindtner, J, Thürlimann, B, Fey, M, Murray, E, Forbes, J, Coates, A, Goldhirsch, A, Spagnoli, Lg
Publikováno v:
Pagani, Olivia; Gelber, Shari; Simoncini, Edda; Castiglione-Gertsch, Monica; Price, Karen; Gelber, Richard; Holmberg, Stig; Crivellari, Diana; Collins, John; Lindtner, Jurij; Thürlimann, Beat; Fey, Martin; Murray, Elizabeth; Forbes, John; Coates, Alan; Goldhirsch, Aron (2009). Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12-93. Breast cancer research and treatment, 116(3), pp. 491-500. Dordrecht: Springer 10.1007/s10549-008-0225-9
To compare the efficacy of chemoendocrine treatment with that of endocrine treatment (ET) alone for postmenopausal women with highly endocrine responsive breast cancer. In the International Breast Cancer Study Group (IBCSG) Trials VII and 12-93, post
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d081215e090f6de0888852e94373d15
https://doi.org/10.5167/uzh-20671
https://doi.org/10.5167/uzh-20671